Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'M-CHLOROPHENYLPIPERAZINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 163 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lerer, B; Macciardi, F; Segman, RH; Adolfsson, R; Blackwood, D; Blairy, S; Del Favero, J; Dikeos, DG; Kaneva, R; Lilli, R; Massat, I; Milanova, V; Muir, W; Noethen, M; Oruc, L; Petrova, T; Papadimitriou, GN; Rietschel, M; Serretti, A; Souery, D; Van Gestel, S; Van Broeckhoven, C; Mendlewicz, J
      Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder

      MOLECULAR PSYCHIATRY
    2. Ben-Zion, IZ; Meiri, G; Shiber, A; Buskila, D; Benjamin, J
      Serotonin blockade does not affect nonarticular tenderness in healthy volunteers

      JOURNAL OF MUSCULOSKELETAL PAIN
    3. Sugimoto, Y; Yoshikawa, T; Noma, T; Yamada, J
      The 5-HT2C/2B receptor agonist m-chlorophenylpiperazine (mCPP) inhibits 2-deoxy-D-glucose (2-DG)-induced hyperphagia in rats

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    4. Baumann, MH; Ayestas, MA; Dersch, CM; Rothman, RB
      1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain

      NEUROPSYCHOPHARMACOLOGY
    5. Erzegovesi, S; Martucci, L; Henin, M; Bellodi, L
      Low versus standard dose mCPP challenge in obsessive-compulsive patients

      NEUROPSYCHOPHARMACOLOGY
    6. Meiri, G; Ben-Zion, IZ; Greenberg, BD; Murphy, DL; Benjamin, J
      Influence of the serotonin antagonist, metergoline, on the anxiogenic effects of carbon dioxide, and on heart rate and neuroendocrine measures, in healthy volunteers

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    7. Tancer, ME; Johanson, CE
      The subjective effects of MDMA and mCPP in moderate MDMA users

      DRUG AND ALCOHOL DEPENDENCE
    8. Khanna, S; John, JP; Reddy, PL
      Neuroendocrine and behavioral responses to mCPP in obsessive-compulsive disorder

      PSYCHONEUROENDOCRINOLOGY
    9. Cath, DC; Spinhoven, P; Landman, AD; van Kempen, GMJ
      Psychopathology and personality characteristics in relation to blood serotonin in Tourette's syndrome and obsessive-compulsive disorder

      JOURNAL OF PSYCHOPHARMACOLOGY
    10. Sanchez, H; Velazquez-Martinez, DN
      Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats

      JOURNAL OF PSYCHOPHARMACOLOGY
    11. Nutt, DJ
      Neurobiological mechanisms in generalized anxiety disorder

      JOURNAL OF CLINICAL PSYCHIATRY
    12. Anthenelli, RM; Maxwell, RA; Geracioti, TD; Hauger, R
      Stress hormone dysregulation at rest and after serotonergic stimulation among alcohol-dependent men with extended abstinence and controls

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    13. Takahashi, RN; Berton, O; Mormede, P; Chaouloff, F
      Strain-dependent effects of diazepam and the 5-HT2B/2C receptor antagonistSB 206553 in spontaneously hypertensive and Lewis rats tested in the elevated plus-maze

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    14. Kim, D; Murray, M; Simansky, KJ
      The serotonergic 5-HT2C agonist m-chlorophenylpiperazine increases weight-supported locomotion without development of tolerance in rats with spinal transections

      EXPERIMENTAL NEUROLOGY
    15. Kirchheiner, J; Brosen, K; Dahl, ML; Gram, LF; Kasper, S; Roots, I; Sjoqvist, F; Spina, E; Brockmoller, J
      CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages

      ACTA PSYCHIATRICA SCANDINAVICA
    16. Broocks, A; Meyer, T; Gleiter, CH; Hillmer-Vogel, U; George, A; Bartmann, U; Bandelow, B
      Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects

      PSYCHOPHARMACOLOGY
    17. Lam, RW; Levitan, RD
      Pathophysiology of seasonal affective disorder: a review

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    18. Naranjo, CA; Knoke, DM; Bremner, KE
      Variations in response to citalopram in men and women with alcohol dependence

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    19. Misane, I; Ogren, SO
      Multiple 5-HT receptors in passive avoidance: Comparative studies of p-chloroamphetamine and 8-OH-DPAT

      NEUROPSYCHOPHARMACOLOGY
    20. Naughton, M; Mulrooney, JB; Leonard, BE
      A review of the role of serotonin receptors in psychiatric disorders

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    21. Pozzi, G; Conte, G; De Risio, S
      Combined use of trazodone-naltrexone versus clonidine-naltrexone in rapid withdrawal from methadone treatment. A comparative inpatient study

      DRUG AND ALCOHOL DEPENDENCE
    22. Markianos, M; Moussas, G; Lykouras, L; Hatzimanolis, J
      Dopamine receptor responsivity in alcoholic patients before and after detoxification

      DRUG AND ALCOHOL DEPENDENCE
    23. Broocks, A; Bandelow, B; George, A; Jestrabeck, C; Opitz, M; Bartmann, U; Gleiter, CH; Meineke, I; Roed, IS; Ruther, E; Hajak, G
      Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    24. Lindenmayer, JP
      The pathophysiology of agitation

      JOURNAL OF CLINICAL PSYCHIATRY
    25. De Vry, J; Schreiber, R
      Effects of selected serotonin 5-HT1 and 5-HT2 receptor agonists on feedingbehavior: possible mechanisms of action

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    26. Anthenelli, RM; Maxwell, RA
      Cigarette smoking decreases the prolactin response to serotonergic stimulation in subgroups of alcoholics and controls

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    27. Soloff, PH; Lynch, KG; Moss, HB
      Serotonin, impulsivity, and alcohol use disorders in the older adolescent:A psychobiological study

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    28. Koskinen, T; Ruotsalainen, S; Puumala, T; Lappalainen, R; Koivisto, E; Mannisto, PT; Sirvio, J
      Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task

      NEUROPHARMACOLOGY
    29. Goeringer, KE; Raymon, L; Logan, BK
      Postmortem forensic toxicology of trazodone

      JOURNAL OF FORENSIC SCIENCES
    30. Yamada, J; Sugimoto, Y
      The 5-HT2C/2B receptor agonist, m-chlorophenylpiperazine, increases plasmaglucagon levels in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    31. Zalma, A; von Moltke, LL; Granda, BW; Harmatz, JS; Shader, RI; Greenblatt, DJ
      In vitro metabolism of trazodone by CYP3A: Inhibition by ketoconazole and human immunodeficiency viral protease inhibitors

      BIOLOGICAL PSYCHIATRY
    32. Rinne, T; Westenberg, HGM; den Boer, JA; van den Brink, W
      Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients

      BIOLOGICAL PSYCHIATRY
    33. Dwyer, D; Browning, J
      Endurance training in Wistar rats decreases receptor sensitivity to a serotonin agonist

      ACTA PHYSIOLOGICA SCANDINAVICA
    34. Boshuisen, ML; den Boer, JA
      Zolmitriptan (a 5-HT1B/1D receptor agonist with central action) does not increase symptoms in obsessive compulsive disorder

      PSYCHOPHARMACOLOGY
    35. Jung, ME; Wallis, CJ; Gatch, MB; Lal, H
      Sex differences in the discriminative stimulus effects of m-chlorophenylpiperazine and ethanol withdrawal

      PSYCHOPHARMACOLOGY
    36. Allen, SM; Davis, WM
      Relationship of dopamine to serotonin in the neonatal 6-OHDA rat model of Lesch-Nyhan syndrome

      BEHAVIOURAL PHARMACOLOGY
    37. Dogrukol-Ak, D; Zaimoglu, V; Tuncel, M
      Voltammetry of trazodone by platinum electrode and its determination in tablets using DP technique in the rotating conditions

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    38. Eriksson, E; Engberg, G; Bing, O; Nissbrandt, H
      Effects of mCPP on the extracellular concentrations of serotonin and dopamine in rat brain

      NEUROPSYCHOPHARMACOLOGY
    39. Broocks, A; Meyer, T; George, A; Hillmer-Vogel, U; Meyer, D; Bandelow, B; Hajak, G; Bartmann, U; Gleiter, CH; Ruther, E
      Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners

      NEUROPSYCHOPHARMACOLOGY
    40. Leone, M; Attanasio, A; Croci, D; D'Amico, D; Grazzi, L; Ferraris, A; Nespolo, A; Bussone, G
      Neuroendocrinology of cluster headache

      ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES
    41. Monteleone, P; La Rocca, A; Fuschino, A; Bortolotti, F; Maj, M
      Seasonal variation in plasma prolactin response to D-fenfluramine in healthy subjects

      PSYCHONEUROENDOCRINOLOGY
    42. Helsley, S; Rabin, RA; Winter, JC
      Further investigations of the serotonergic properties of the ibogaine-induced discriminative stimulus

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    43. Rotzinger, S; Bourin, M; Akimoto, Y; Coutts, RT; Baker, GB
      Metabolism of some "second"- and "fourth"-generation antidepressants: Iprindole, viloxazine, bupropion, mianserin, maprotiline, trazodone, nefazodone, and venlafaxine

      CELLULAR AND MOLECULAR NEUROBIOLOGY
    44. Franklin, M; Craven, RD; Dowling, B; Campling, G; Elliott, JM; Cowen, PJ
      Effect of a long-term low tryptophan diet on the prolactin responses to the 5-HT1A and 5-HT2C agonists, 8-OH-DPAT and mCPP in the male rat

      JOURNAL OF PSYCHOPHARMACOLOGY
    45. Goddard, AW; Woods, SW; Money, R; Pande, AC; Charney, DS; Goodman, WK; Heninger, GR; Price, LH
      Effects of the CCKB antagonist CI-988 on responses to mCPP in generalized anxiety disorder

      PSYCHIATRY RESEARCH
    46. Gommans, J; Hijzen, TH; Pattij, T; Van der Gugten, J; Olivier, B
      Discriminative stimulus properties of mCPP and alprazolam are not mediatedby anxiety

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    47. Epperson, CN; Wisner, KL; Yamamoto, B
      Gonadal steroids in the treatment of mood disorders

      PSYCHOSOMATIC MEDICINE
    48. Dekeyne, A; Girardon, S; Millan, MJ
      Discriminative stimulus properties of the novel serotonin (5-HT)(2C) receptor agonist, RO 60-0175: a pharmacological analysis

      NEUROPHARMACOLOGY
    49. Nelson, DL; Lucaites, VL; Wainscott, DB; Glennon, RA
      Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    50. Pazzagli, M; Giovannini, MG; Pepeu, G
      Trazodone increases extracellular serotonin levels in the frontal cortex of rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    51. Lappalainen, J; Long, JC; Virkkunen, M; Ozaki, N; Goldman, D; Linnoila, M
      HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses

      BIOLOGICAL PSYCHIATRY
    52. Tozawa, Y; Ueki, A; Shimosawa, T; Fujita, T
      5-HT2A/2C receptor agonist-induced increase in urinary isatin excretion inrats - Reversal by both diazepam and dexamethasone

      BIOCHEMICAL PHARMACOLOGY
    53. Murphy, DL; Wichems, C; Li, Q; Heils, A
      Molecular manipulations as tools for enhancing our understanding of 5-HT neurotransmission

      TRENDS IN PHARMACOLOGICAL SCIENCES
    54. O'Dell, LE; Kreifeldt, MJ; George, FR; Ritz, MC
      Serotonin(2C) receptors appear to mediate genetic sensitivity to cocaine-induced convulsions

      PSYCHOPHARMACOLOGY
    55. Cath, DC; Gijsman, HJ; Schoemaker, RC; van Griensven, JMT; Troost, N; van Kempen, GMJ; Cohen, AF
      The effect of m-CPP on tics and obsessive-compulsive phenomena in Gilles de la Tourette syndrome

      PSYCHOPHARMACOLOGY
    56. YAO V; SHAH VR; SHYU WC; SRINIVAS NR
      SENSITIVE LIQUID-CHROMATOGRAPHIC MASS-SPECTROMETRIC ASSAY FOR THE SIMULTANEOUS QUANTITATION OF NEFAZODONE AND ITS METABOLITES HYDROXYNEFAZODONE M-CHLOROPHENYLPIPERAZINE AND TRIAZOLE-DIONE IN HUMAN PLASMA USINGSINGLE-ION MONITORING

      Journal of chromatography B. Biomedical sciences and applications
    57. TERENIUS L
      RATIONAL TREATMENT OF ADDICTION

      Current opinion in chemical biology
    58. BLUNDELL JE; HALFORD JCG
      SEROTONIN AND APPETITE REGULATION - IMPLICATIONS FOR THE PHARMACOLOGICAL TREATMENT OF OBESITY

      CNS DRUGS
    59. LEONE M; ATTANASIO A; CROCI D; FERRARIS A; DAMICO D; GRAZZI L; NESPOLO A; BUSSONE G
      5-HT1A RECEPTOR HYPERSENSITIVITY IN MIGRAINE IS SUGGESTED BY THE M-CHLOROPHENYLPIPERAZINE TEST

      NeuroReport
    60. JENCK F; MOREAU JL; BERENDSEN HHG; BEES M; BROEKKAMP CLE; MARTIN JR; WICHMANN J; VANDELFT AML
      ANTIAVERSIVE EFFECTS OF 5HT(2C) RECEPTOR AGONISTS AND FLUOXETINE IN AMODEL OF PANIC-LIKE ANXIETY IN RATS

      European neuropsychopharmacology
    61. Stern, L; Zohar, J; Cohen, R; Sasson, Y
      Treatment of severe, drug resistant obsessive compulsive disorder with the5HT(1D) agonist sumatriptan

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    62. BROOCKS A; PIGOTT TA; HILL JL; CANTER S; GRADY TA; LHEUREUX F; MURPHY DL
      ACUTE INTRAVENOUS ADMINISTRATION OF ONDANSETRON AND M-CPP, ALONE AND IN COMBINATION, IN PATIENTS WITH OBSESSIVE-COMPULSIVE DISORDER(OCD) - BEHAVIORAL AND BIOLOGICAL RESULTS

      Psychiatry research
    63. OTANI K; TYBRING G; MIHARA K; YASUI N; KANEKO S; OHKUBO T; NAGASAKI T; SUGAWARA K
      CORRELATION BETWEEN STEADY-STATE PLASMA-CONCENTRATIONS OF MIANSERIN AND TRAZODONE IN DEPRESSED-PATIENTS

      European Journal of Clinical Pharmacology
    64. MARCOLI M; MAURA G; TORTAROLO M; RAITERI M
      TRAZODONE IS A POTENT AGONIST AT 5-HT2C RECEPTORS MEDIATING INHIBITION OF THE N-METHYL-D-ASPARTATE NITRIC-OXIDE CYCLIC-GMP PATHWAY IN RAT CEREBELLUM

      The Journal of pharmacology and experimental therapeutics
    65. UPTON N; STEAN T; MIDDLEMISS D; BLACKBURN T; KENNETT G
      STUDIES ON THE ROLE OF 5-HT2C AND 5-HT2B RECEPTORS IN REGULATING GENERALIZED SEIZURE THRESHOLD IN RODENTS

      European journal of pharmacology
    66. Nacca, A; Guiso, G; Fracasso, C; Cervo, L; Caccia, S
      Brain-to-blood partition and in vivo inhibition of 5-hydroxytryptamine reuptake and quipazine-mediated behaviour of nefazodone and its main active metabolites in rodents

      BRITISH JOURNAL OF PHARMACOLOGY
    67. MILLET B; TOUITOU Y; POIRIER MF; BOURDEL HC; HANTOUCHE E; BOGDAN A; OLIE JP
      PLASMA MELATONIN AND CORTISOL IN PATIENTS WITH OBSESSIVE-COMPULSIVE DISORDER - RELATIONSHIP WITH AXILLARY TEMPERATURE, PHYSICAL-ACTIVITY, AND CLINICAL SYMPTOMS

      Biological psychiatry
    68. SALLEE FR; KORAN LM; PALLANTI S; CARSON SW; SETHURAMAN G
      INTRAVENOUS CLOMIPRAMINE CHALLENGE IN OBSESSIVE-COMPULSIVE DISORDER -PREDICTING RESPONSE TO ORAL-THERAPY AT 8 WEEKS

      Biological psychiatry
    69. ROTZINGER S; FANG J; COUTTS RT; BAKER GB
      HUMAN CYP2D6 AND METABOLISM OF M-CHLOROPHENYLPIPERAZINE

      Biological psychiatry
    70. BROOCKS A; LITTLE JT; MARTIN A; MINICHIELLO MD; DUBBERT B; MACK C; TUNE L; MURPHY DL; SUNDERLAND T
      THE INFLUENCE OF ONDANSETRON AND M-CHLOROPHENYLPIPERAZINE ON SCOPOLAMINE-INDUCED COGNITIVE, BEHAVIORAL, AND PHYSIOLOGICAL-RESPONSES IN YOUNG HEALTHY CONTROLS

      Biological psychiatry
    71. Pian, KLH; Westerberg, HGM; van Megen, HJGM; den Boer, JA
      Sumatriptan (5-HT1D receptor agonist) does not exacerbate symptoms in obsessive compulsive disorder

      PSYCHOPHARMACOLOGY
    72. GOMMANS J; HIJZEN TH; MAES RAA; OLIVIER B
      DISCRIMINATIVE STIMULUS PROPERTIES OF MCPP - EVIDENCE FOR A 5-HT2C RECEPTOR MODE OF ACTION

      Psychopharmacology
    73. BAGDY G; ARATO M
      GENDER-DEPENDENT DISSOCIATION BETWEEN OXYTOCIN BUT NOT ACTH, CORTISOLOR TSH RESPONSES TO M-CHLOROPHENYLPIPERAZINE IN HEALTHY-SUBJECTS

      Psychopharmacology
    74. MITCHELL PJ; REDFERN PH
      POTENTIATION OF THE TIME-DEPENDENT, ANTIDEPRESSANT-INDUCED CHANGES INTHE AGONISTIC BEHAVIOR OF RESIDENT RATS BY THE 5-HT1A RECEPTOR ANTAGONIST, WAY-100635

      Behavioural pharmacology
    75. MEERT TF; MELIS W; AERTS N; CLINCKE G
      ANTAGONISM OF META-CHLOROPHENYLPIPERAZINE-INDUCED INHIBITION OF EXPLORATORY ACTIVITY IN AN EMERGENCE PROCEDURE, THE OPEN-FIELD TEST, IN RATS

      Behavioural pharmacology
    76. PRICE LH; MALISON RT; MCDOUGLE CJ; MCCANCEKATZ EF; OWEN KR; HENINGER GR
      NEUROBIOLOGY OF TRYPTOPHAN DEPLETION IN DEPRESSION - EFFECTS OF M-CHLOROPHENYLPIPERAZINE (MCPP)

      Neuropsychopharmacology
    77. SU TP; SCHMIDT PJ; DANACEAU MA; TOBIN MB; ROSENSTEIN DL; MURPHY DL; RUBINOW DR
      FLUOXETINE IN THE TREATMENT OF PREMENSTRUAL DYSPHORIA

      Neuropsychopharmacology
    78. LEONE M; ATTANASIO A; CROCI D; LIBRO G; GRAZZI L; DAMICO D; NESPOLO A; BUSSONE G
      THE M-CHLOROPHENYLPIPERAZINE TEST IN CLUSTER HEADACHE - A STUDY ON CENTRAL SEROTONINERGIC ACTIVITY

      Cephalalgia
    79. PANCONESI A; SICUTERI R
      HEADACHE INDUCED BY SEROTONERGIC AGONISTS - A KEY TO THE INTERPRETATION OF MIGRAINE PATHOGENESIS

      Cephalalgia
    80. HOMMER D; ANDREASEN P; RIO D; WILLIAMS W; RUTTIMANN U; MOMENAN R; ZAMETKIN A; RAWLINGS R; LINNOILA M
      EFFECTS OF M-CHLOROPHENYLPIPERAZINE ON REGIONAL BRAIN GLUCOSE-UTILIZATION - A POSITRON EMISSION TOMOGRAPHIC COMPARISON OF ALCOHOLIC AND CONTROL SUBJECTS

      The Journal of neuroscience
    81. WEISS D; COCCARO EF
      NEUROENDOCRINE CHALLENGE STUDIES OF SUICIDAL-BEHAVIOR

      The Psychiatric clinics of North America
    82. MAJ J; KOLODZIEJCZYK K; ROGOZ Z; SKUZA G
      ROXINDOLE, A DOPAMINE AUTORECEPTOR AGONIST WITH A POTENTIAL ANTIDEPRESSANT ACTIVITY .2. EFFECTS ON THE 5-HYDROXYTRYPTAMINE SYSTEM

      Pharmacopsychiatry
    83. MIHARA K; OTANI K; ISHIDA M; YASUI N; SUZUKI A; OHKUBO T; OSANAI T; KANEKO S; SUGAWARA K
      INCREASES IN PLASMA-CONCENTRATION OF M-CHLOROPHENYLPIPERAZINE, BUT NOT TRAZODONE, WITH LOW-DOSE HALOPERIDOL

      Therapeutic drug monitoring
    84. MCDOUGLE CJ
      UPDATE ON PHARMACOLOGICAL MANAGEMENT OF OCD - AGENTS AND AUGMENTATION

      The Journal of clinical psychiatry
    85. WOLFE BE; METZGER ED; JIMERSON DC
      RESEARCH UPDATE ON SEROTONIN FUNCTION IN BULIMIA-NERVOSA AND ANOREXIA-NERVOSA

      Psychopharmacology bulletin
    86. ELMANSARI M; BLIER P
      IN-VIVO ELECTROPHYSIOLOGICAL CHARACTERIZATION OF 5-HT RECEPTORS IN THE GUINEA-PIG HEAD OF CAUDATE-NUCLEUS AND ORBITOFRONTAL CORTEX

      Neuropharmacology
    87. DUXON MS; KENNETT GA; LIGHTOWLER S; BLACKBURN TP; FONE KCF
      ACTIVATION OF 5-HT2B RECEPTORS IN THE MEDIAL AMYGDALA CAUSES ANXIOLYSIS IN THE SOCIAL-INTERACTION TEST IN THE RAT

      Neuropharmacology
    88. VATASSERY GT; HOLDEN LA; HAZEL DK; DYSKEN MW
      DETERMINATION OF TRAZODONE AND ITS METABOLITE, 1-M-CHLOROPHENYL-PIPERAZINE, IN HUMAN PLASMA AND RED-BLOOD-CELL SAMPLES BY HPLC

      Clinical biochemistry
    89. KIM SW; DYSKEN MW; KUSHNER MG; KUSKOWSKI MA; HOOVER KM; KLEIN KW; FARIS PL; HARTMAN BK
      PHENOMENOLOGICAL AND PHARMACOLOGICAL STUDY OF PROVOKED OBSESSIVE ANXIETY SYMPTOMS IN OBSSESIVE-COMPULSIVE DISORDER - A PRELIMINARY-STUDY/

      Biological psychiatry
    90. LINDENMAYER JP; ADITYANJEE; VITALHERNE M; BARK N; GROCHOWSKI S; MOYNIHAN N
      HETEROGENEITY OF SEROTONERGIC RESPONSE IN TREATMENT-REFRACTORY SCHIZOPHRENIA-PATIENTS

      Biological psychiatry
    91. SOUTHWICK SM; KRYSTAL JH; BREMNER JD; MORGAN CA; NICOLAOU AL; NAGY LM; JOHNSON DR; HENINGER GR; CHARNEY DS
      NORADRENERGIC AND SEROTONERGIC FUNCTION IN POSTTRAUMATIC-STRESS-DISORDER

      Archives of general psychiatry
    92. JIMERSON DC; WOLFE BE; METZGER ED; FINKELSTEIN DM; COOPER TB; LEVINE JM
      DECREASED SEROTONIN FUNCTION IN BULIMIA-NERVOSA

      Archives of general psychiatry
    93. QUESTED DJ; SARGENT PA; COWEN PJ
      SSRI TREATMENT DECREASES PROLACTIN AND HYPERTHERMIC RESPONSES TO MCPP

      Psychopharmacology
    94. GRANT KA; COLOMBO G; GATTO GJ
      CHARACTERIZATION OF THE ETHANOL-LIKE DISCRIMINATIVE STIMULUS EFFECTS OF 5-HT RECEPTOR AGONISTS AS A FUNCTION OF ETHANOL TRAINING DOSE

      Psychopharmacology
    95. MIHARA K; OTANI K; SUZUKI A; YASUI N; NAKANO H; MENG XM; OHKUBO T; NAGASAKI T; KANEKO S; TSUCHIDA S; SUGAWARA K; GONZALEZ FJ
      RELATIONSHIP BETWEEN THE CYP2D6 GENOTYPE AND THE STEADY-STATE PLASMA-CONCENTRATIONS OF TRAZODONE AND ITS ACTIVE METABOLITE M-CHLOROPHENYLPIPERAZINE

      Psychopharmacology
    96. KRYSTAL JH; WEBB E; GRILLON C; COONEY N; CASAL L; MORGAN CA; SOUTHWICK SM; DAVIS M; CHARNEY DS
      EVIDENCE OF ACOUSTIC STARTLE HYPERREFLEXIA IN RECENTLY DETOXIFIED EARLY-ONSET MALE ALCOHOLICS - MODULATION BY YOHIMBINE AND M-CHLOROPHENYLPIPERAZINE (MCPP)

      Psychopharmacology
    97. MAZZOLAPOMIETTO P; AULAKH CS; TOLLIVER T; MURPHY DL
      FUNCTIONAL SUBSENSITIVITY OF 5-HT2A AND 5-HT2C RECEPTORS MEDIATING HYPERTHERMIA FOLLOWING ACUTE AND CHRONIC TREATMENT WITH 5-HT2A 2C RECEPTOR ANTAGONISTS/

      Psychopharmacology
    98. BOELES S; WILLIAMS C; CAMPLING GM; GOODALL EM; COWEN PJ
      SUMATRIPTAN DECREASES FOOD-INTAKE AND INCREASES PLASMA GROWTH-HORMONEIN HEALTHY WOMEN

      Psychopharmacology
    99. JARRY JL; VACCARINO FJ
      EATING DISORDER AND OBSESSIVE-COMPULSIVE DISORDER - NEUROCHEMICAL ANDPHENOMENOLOGICAL COMMONALITIES

      Journal of psychiatry & neuroscience
    100. THOMAS DR; GAGER TL; HOLLAND V; BROWN AM; WOOD MD
      M-CHLOROPHENYLPIPERAZINE (MCPP) IS AN ANTAGONIST AT THE CLONED HUMAN 5-HT2B RECEPTOR

      NeuroReport


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 17/02/20 alle ore 08:01:21